Genmab A/S (GNMSF) FCF Payout Ratio (2024 - 2026)
Genmab A's (GNMSF) quarterly FCF Payout Ratio came in at 507.0 in Q1 2026, up 8887.58% YoY from 5.64 in Q1 2025, and up 25379.56% on a QoQ basis from 1.99 in Q3 2025.
Genmab A/S (GNMSF) FCF Payout Ratio (2024 - 2026) Analysis & Trends
Genmab A (GNMSF) has 3 years of FCF Payout Ratio data on file, last reported at 507.0 in Q1 2026.
- Quarterly FCF Payout Ratio rose 8887.58% year-over-year to 507.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.1 (up 62.17% YoY) and the FY2024 annual result came in at 1.26, down 42.0% from the prior year.
- FCF Payout Ratio improved to 507.0 in Q1 2026, from 1.99 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 507.0 in Q1 2026 to a low of 1.29 in Q3 2024.
- A 3-year average of 75.86 and a median of 3.96 in 2025 frame the typical range for FCF Payout Ratio.
- Annual changes were most pronounced in 2025 — FCF Payout Ratio tumbled 41.92% — and 2026, when it soared 8887.58%.
- Tracing GNMSF's FCF Payout Ratio over 3 years: stood at 1.29 in 2024, then surged by 54.04% to 1.99 in 2025, then soared by 25379.56% to 507.0 in 2026.
- The last three FCF Payout Ratio figures came in at 507.0 (Q1 2026), 1.99 (Q3 2025), and 3.96 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 507.00 |
| Sep 30, 2025 | 1.99 |
| Jun 30, 2025 | 3.96 |
| Mar 31, 2025 | 5.64 |
| Sep 30, 2024 | 1.29 |
| Jun 30, 2024 | 1.45 |
| Mar 31, 2024 | 9.71 |